Harte Hanks

FY2025: operating revenue ~$159.6M (−13.9% vs. ~$185.2M FY2024); operating income ~$0.4M; net loss ~$(0.8)M ($(0.11)/share) vs. large FY2024 loss driven in part by pension termination charges. Q4 2025: revenue ~$39.9M (−15.4% vs. prior year); net income ~$2.2M ($0.30/share). Cash ~$5.6M, no outstanding debt, ~$24M credit line capacity — Mar 17, 2026 EX-99.1.

If you own HHS, you are weighing a shrinking revenue base against positive FY EBITDA, zero debt, and whether Fulfillment & Logistics stabilizes after a cited customer exit.

hhs

communication services · CX services micro cap updated mar 27, 2026
$2.80
market cap ~$21M illustrative (~$2.80 × ~7.4M wa shares FY) · verify
xvary composite: 37 / 100 · weak
our overall rating — combines growth, value, risk, and momentum
Start here if you're new
what it is
Harte Hanks is a customer experience (CX) company: strategy, analytics, and execution across Customer Care, Fulfillment & Logistics, and Revenue Solutions — per company filings.
how it gets paid
FY2025 operating revenue ~$159.6M (−13.9% vs. prior year). Largest segment: Fulfillment & Logistics ~$74.4M; Customer Care ~$50.1M; Revenue Solutions ~$35.1M — segment table, EX-99.1.
why the numbers moved
FY2024 net loss included ~$37.5M pension plan termination charges (per release). FY2025 is a smaller $(0.11) EPS loss with positive EBITDA ~$4.9M and Adj. EBITDA ~$6.9M — still a declining top line.
what just happened
Q4 2025 revenue ~$39.9M (−15.4% vs. prior year); net income ~$2.2M ($0.30/share). Logistics revenue pressured by a customer exit earlier in 2025 — EX-99.1.
At a glance
C+ balance sheet — struggling to keep the lights on
15/100 earnings predictability — expect surprises
return on capital — not verified on this page
$(0.11) FY2025 GAAP EPS
~$159.6M FY2025 revenue
xvary composite: 37/100 — weak
What they do
Harte Hanks partners with brands on customer experience: data-driven CX strategy plus execution in care centers, fulfillment/logistics, and revenue solutions.
Not a SaaS multiple story — a ~2,100-employee services footprint (per release) with named enterprise clients and proprietary program execution. Scale is modest; switching costs sit in embedded programs and logistics relationships, which can unwind when clients exit.
cx-services micro-cap marketing-services b2b services
How they make money
~$159.6M FY2025 operating revenue · −13.9% vs. prior year (FY2024 ~$185.2M) · EX-99.1
total operating revenue
~$159.6M
−13.9%
Fulfillment & Logistics
~$74.4M
vs ~$82.0M FY2024
Customer Care
~$50.1M
vs ~$52.9M FY2024
Revenue Solutions
~$35.1M
vs ~$50.3M FY2024
The products that matter
largest segment · FY2025
Fulfillment & Logistics
~$74.4M revenue (~47% of total)
Q4 narrative: revenue down vs. prior year partly from a logistics customer exit earlier in 2025. This line still drives the top line — volatility here moves the whole company.
core
call center & CX operations
Customer Care
~$50.1M FY2025; Q4 ~$13.7M
Release cites investment in a new call center and expanded Samsung relationship in H2 2025 — watch EBITDA contribution as investments mature.
ops
data & revenue programs
Revenue Solutions
~$35.1M FY2025 (−30% vs ~$50.3M FY2024)
Smallest segment and shrinking fastest vs. prior year — turnaround needs this bucket to stabilize or be offset elsewhere.
pressure
Key numbers
~$159.6M
FY2025 revenue
Down 13.9% vs. prior year — micro-cap with shrinking sales is the core tension vs. balance-sheet cleanup.
~0.2%
GAAP op. margin FY2025
Operating income ~$0.4M on ~$159.6M revenue — effectively breakeven at the operating line. Adj. operating margin ~1.5% per EX-99.1 reconciliation.
~$4.9M
EBITDA FY2025
Company highlights positive FY EBITDA; Adj. EBITDA ~$6.9M — non-GAAP; see filing reconciliation.
$0
debt · cash
No outstanding debt Dec 31, 2025; cash ~$5.6M; ~$24M undrawn credit capacity — EX-99.1.
Financial health
C+
strength
  • balance sheet grade C+ — weak — may struggle to fund operations
  • risk rank 3 — safer than 50% of stocks
  • price stability 20 / 100
  • debt · liquidity no outstanding debt · ~$5.6M cash · ~$24M credit line (EX-99.1)
C+ — composite grade; filing shows no term debt but low cash, leases, and pension/other liabilities — read 10-K.
Total return vs. market

Return history isn't available for HHS right now.

source: n/a — verify total return vs. benchmark independently
What just happened
reported results
Q4 2025: operating revenue ~$39.9M (−15.4% vs. ~$47.1M Q4 2024). Net income ~$2.2M ($0.30/share) vs. net loss ~$(2.4)M ($(0.33)) prior-year Q4.
FY2025: revenue ~$159.6M (−13.9%); net loss ~$(0.8)M ($(0.11)/share) vs. FY2024 net loss ~$(30.3)M (incl. pension termination charges). Q4 EBITDA ~$1.0M vs. negative prior-year quarter; Adj. EBITDA ~$1.2M vs. ~$3.5M Q4 2024.
~$39.9M
Q4 revenue
$0.30
Q4 EPS
$(0.11)
FY2025 EPS
the number that mattered
Whether segment revenue declines (especially Logistics after the cited customer exit) stabilize in 2026 — Q4 profit benefited from mix and prior-year impairments; the top line was still down double digits vs. prior year.
source: SEC Form 8-K EX-99.1, filed Mar 18, 2026 (FY2025 / Q4 2025)

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.

weekly updates earnings alerts plain english no spam
What could go wrong

The #1 risk is continued revenue erosion across segments — Q4 2025 was ~$39.9M (−15.4% vs. prior year) after a year when FY revenue fell ~14%. Client exits (cited in logistics) and budget cuts hit harder at this scale.

!
high
contract disruption
Earnings narrative flags program timing, call-center investment, and relationship concentration (e.g. Samsung called out in Q4).
few large programs can move quarterly EBITDA
!
high
Revenue Solutions & Logistics headwinds
Revenue Solutions fell ~30% FY2025 vs. prior year (~$35M vs ~$50M). Fulfillment & Logistics fell ~9% with a cited customer exit.
both are structural demand signals, not rounding error
med
tariffs and supply chain strain
Fulfillment & Logistics is exposed to client supply chains, postage/paper/fuel-type costs — see 10-K risk factors.
macro + client consolidation can compress spend
med
Thin GAAP operating buffer
FY2025 GAAP operating income was only ~$0.4M on ~$159.6M revenue — little room for revenue misses or cost spikes.
cash ~$5.6M — liquidity matters if operations wobble
Micro-cap CX vendor with a falling top line and minimal GAAP operating income — execution and retention matter more than valuation ratios.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
segment revenue trends
Watch whether Revenue Solutions stops shrinking and Logistics comps ease post–customer exit — segment tables in EX-99.1.
calendar
next filings
FY2025 results released Mar 17, 2026 (8-K Mar 18, 2026). Forward estimates not verified on this page.
trend
FY2025 ~$159.6M vs. FY2024 ~$185.2M
The clean comparison is reported GAAP revenue — still declining. EBITDA improvement does not replace top-line stabilization.
risk
client transitions and contract timing
management already flagged program transitions. on a company this size, a few delayed or lost contracts can change the quarter fast.
Analyst rankings
earnings predictability
15 / 100
earnings can swing around. in human-speak, analysts do not trust this business to print clean, repeatable quarters.
risk rank
3
that is roughly middle-of-the-pack risk. the balance sheet is not the main problem. the business trend is.
price stability
20 / 100
the stock has been unstable. micro-cap turnarounds usually are.
valuation lens
no clean P/E
FY2025 GAAP net loss (~$(0.11)/share) makes trailing P/E misleading — use EBITDA, segment trends, and balance sheet from filings before sizing “cheap.”
source: institutional data · filing facts from EX-99.1
Institutional activity

institutional ownership data for HHS is being compiled.

source: institutional data
Price targets
3-5 year target range
n/a n/a
$2.80 current price
n/a target midpoint · n/a from current
target data not available

Want the deeper analysis?

The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

see plans from $5/mo
The deep dive
HHS
xvary deep dive
hhs
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it